2008 Process Chemistry Trials 
Metabolite Tales Blog
JULY 5, 2023
However, more de novo designed molecules in this “beyond the Rule of 5 chemical space” have emerged, with the first in this class, plerixafor , approved in oncology in 2008. Still, of the 34 macrocycles currently in clinical trials, only 18% are de novo designed. Journal of Medicinal Chemistry 62 (21), 9418-9437. Balazs et al.,
Metabolite Tales Blog
JULY 5, 2023
2] However, more de novo designed molecules in this “beyond the Rule of 5 chemical space” have emerged, with the first in this class, plerixafor , approved in oncology in 2008. Still, of the 34 macrocycles currently in clinical trials, only 18% are de novo designed. Journal of Medicinal Chemistry 62 (21), 9418-9437.
Expert insights. Personalized for you.
52 
Let's personalize your content